Platelet glycoprotein IIb/IIIa inhibitors: basic and clinical aspects.
about
Glanzmann thrombastheniaHaemostaseologyUse of glycoprotein IIb/IIIa inhibitors in unstable angina and non-ST-elevation myocardial infarction.Risk of thrombocytopenia with glycoprotein IIb/IIIa inhibitors across drugs and patient populations: a meta-analysis of 29 large placebo-controlled randomized trials.Efficacy and safety of abciximab in diabetic patients who underwent percutaneous coronary intervention with thienopyridines loading: a meta-analysis.Lytic resistance of fibrin containing red blood cells.Treatments for stroke.Optimal use of platelet glycoprotein IIb/IIIa receptor antagonists in patients undergoing percutaneous coronary interventions.Review of Currently Available GP IIb/IIIa Inhibitors and Their Role in Peripheral Vascular Interventions.Anti-platelet therapy in small animal medicine.Platelet-derived microparticles and platelet function profile in children with congenital heart disease.Delayed tirofiban-induced thrombocytopenia: two case reports.Abciximab and left ventricular thrombus formation in early period of acute myocardial infarction treated with successful primary stenting.The effect of glycoprotein IIIa PIA 1/A2 polymorphism on the PFA-100 response to GP IIb IIa receptor inhibitors-the importance of anticoagulants used.Pharmacokinetic and pharmacodynamic properties of batifiban coadministered with antithrombin agents in Chinese healthy volunteers.
P2860
Q21203054-F8D978EB-F000-4137-AD3A-A5952C259FBEQ28182273-C3072DC1-C183-4D04-A1A5-11C26B32C935Q33369310-75A0FCF3-9476-4915-A485-0C7FCE3D1EEDQ33434702-CFDCEF06-9A92-43FE-A055-8C093EA10912Q33934090-710EA91F-0B61-4C6C-A68B-B10E6E1B3D54Q33954228-FE2678D9-6D21-47B1-833E-A32783A752C3Q35581150-2839462A-88B7-43D0-9FC9-18ACDF6DED9DQ37943829-7EEEE980-0257-4098-A268-208174B3FFDDQ38006947-0643FC6B-915F-4B24-A244-D9D45070A2B0Q38770733-B52C25B6-CA85-4571-B676-1511473E0025Q46094023-B086264A-4EE8-4DB5-B6A1-E7D82F34A556Q46470741-E8BB660B-FD87-4035-B1E8-88E979B0CCEAQ46613791-42C0D70C-1758-4818-A59F-ACB65CF6CF92Q46679754-0FFBDD9D-983D-464D-ABDE-A9547D2F65A6Q54723126-CE29C491-A34A-4B10-A9DA-90C69F5F4601
P2860
Platelet glycoprotein IIb/IIIa inhibitors: basic and clinical aspects.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Platelet glycoprotein IIb/IIIa inhibitors: basic and clinical aspects.
@ast
Platelet glycoprotein IIb/IIIa inhibitors: basic and clinical aspects.
@en
type
label
Platelet glycoprotein IIb/IIIa inhibitors: basic and clinical aspects.
@ast
Platelet glycoprotein IIb/IIIa inhibitors: basic and clinical aspects.
@en
prefLabel
Platelet glycoprotein IIb/IIIa inhibitors: basic and clinical aspects.
@ast
Platelet glycoprotein IIb/IIIa inhibitors: basic and clinical aspects.
@en
P2093
P1476
Platelet glycoprotein IIb/IIIa inhibitors: basic and clinical aspects
@en
P2093
A T Nurden
C Durrieu-Jais
P304
P356
10.1161/01.ATV.19.12.2835
P407
P577
1999-12-01T00:00:00Z